Click Here to return To Results

 

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis NEJM 366:1000-1009, Comi,G.,et al, 2012 See this aricle in Pubmed Article Abstract In this phase 3 study, oral laquinimod administered once daily slowed the progression of disability and reduced the rate of relapse in patients with relapsing-remitting multiple sclerosis.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction complications efficacy laquinimod liver function enzymes multiple sclerosis multiple sclerosis,prophylaxsis multiple sclerosis,relapsing multiple sclerosis,treatment of safety treatment of neurologic disorder

Click Here to return To Results